|1.||Brugada, Pedro: 14 articles (03/2014 - 01/2004)|
|2.||Sarkozy, Andrea: 8 articles (03/2014 - 11/2005)|
|3.||Chierchia, Gian-Battista: 7 articles (03/2014 - 01/2010)|
|4.||de Asmundis, Carlo: 5 articles (03/2014 - 01/2010)|
|5.||Batchvarov, Velislav N: 5 articles (11/2011 - 05/2009)|
|6.||Behr, Elijah R: 5 articles (11/2011 - 05/2009)|
|7.||Brugada, Ramon: 5 articles (08/2008 - 01/2004)|
|8.||Brugada, P: 4 articles (10/2014 - 02/2000)|
|9.||Govindan, Malini: 4 articles (12/2010 - 05/2009)|
|10.||Borggrefe, Martin: 4 articles (10/2009 - 04/2002)|
|1.||Cardiac Arrhythmias (Arrythmia)
01/01/1986 - "Ajmaline infusion produced in 40% of the cases a total suppression and in 100% a significant improvement of malignant ventricular arrhythmia. "
07/01/1990 - "LV diastolic filling is improved after acute application of ajmaline in patients with CAD and normal systolic function; its application may be advised not only for therapy of arrhythmia but also to improve left ventricular diastolic mechanics in these patients."
04/01/1989 - "Pharmacokinetics and antiarrhythmic efficacy of intravenous ajmaline in ventricular arrhythmia of acute onset."
04/01/1975 - "The antiarrhythmic efficacy of ajmaline has been evaluated in three experimental models of cardiac arrhythmias in the dog. "
12/02/1963 - "[CLINICAL STUDIES ON THE THERAPEUTIC VALUE OF AJMALINE IN CARDIAC ARRHYTHMIAS]."
12/01/1969 - "[A case of ventricular tachycardia treated successfully with ajmaline]."
05/01/1985 - "Efficacy of intravenous ajmaline in ventricular tachycardia."
01/01/2015 - "Ajmaline-induced sustained ventricular tachycardia occurred in one patient with BrP, who finally received an ICD. "
09/01/2013 - "Here, we present a rare case of monomorphic ventricular tachycardia, which was observed during the ajmaline challenge test. "
09/01/2013 - "[Monomorphic ventricular tachycardia during the ajmaline test]."
06/01/1980 - "Long-term oral therapy with ajmaline has proved effective in preventing recurrent tachyarrhythmias. "
12/01/2004 - "Ajmaline is a class Ia anti-arrhythmic drug used in several European countries and Japan as first-line treatment for ventricular tachyarrhythmia. "
01/19/2001 - "The aims of the present study were (1) to determine whether ajmaline administration modifies the rate-dependent properties of the AV node and (2) to correlate these changes with the actions of ajmaline on an in vitro model of AV re-entrant tachycardia. "
04/01/2000 - "At the electrophysiology study, a prolonged HV interval was observed at baseline, and the tachycardia could be reproduced after ajmaline infusion. "
02/01/2013 - "Re-entry tachycardia occurred a second time six days after ablation, and as before, it was stopped only with ajmaline. "
|4.||Wolff-Parkinson-White Syndrome (Wolf-Parkinson-White Syndrome)
06/01/1980 - "We conclude that ajmaline is specifically effective and safe in the treatment of the WPW syndrome."
01/01/1989 - "In a patient with the Wolff-Parkinson-White syndrome, the existence of dual accessory pathways, both right-sided, was suspected during ajmaline test and confirmed during electrophysiologic study. "
04/01/1986 - "Comparison of exercise and ajmaline tests with electrophysiologic study in the Wolff-Parkinson-White syndrome."
06/01/1980 - "Ajmaline in WPW syndrome: an electrophysiologic study."
02/01/2013 - "Since electrocardiography showed a delta-wave, Wolff-Parkinson-White (WPW) syndrome was diagnosed, ajmaline prescribed and radio-frequency catheter ablation of three accessory pathways carried out one week later. "
11/01/1982 - "Seven patients with right precordial Q waves (RPQs) simulating anterior myocardial infarction (MI), but without a previous history of either MI or other underlying diseases showing RPQ, were injected intravenously with ajmaline. "
11/01/1982 - "Effects of ajmaline on right precordial Q waves simulating myocardial infarction."
09/01/1982 - "On the other hand, in 43 Ajmaline tests without VT in patients with myocardial infarction, 6 cases of VT and 1 lethal VF were later observed. "
09/01/1982 - "--Three other cases of abnormal ventricular excitability complicating the administration of 1 mg/kg of Ajmaline to test for paroxysmal block after myocardial infarction. "
09/01/1993 - "As yet the antiarrhythmic efficacy of ajmaline with regard to suppressing the induction of sustained ventricular tachycardia after myocardial infarction has not been determined. "
|1.||Implantable Defibrillators (Implantable Cardioverter-Defibrillator)
|3.||Electric Countershock (Cardioversion)